Found 8 matching trials
Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study) PHASE3 The primary purpose is to assess the efficacy of once daily dosing with opt...
Show More Location
Clinical Study Centers, LLC
Learn More & Join Trial
Extended-release Guanfacine Hydrochloride in Children/Adolescents With Attention-deficit/Hyperactivity PHASE3 A study to evaluate the long term maintenance of efficacy of using Guanfaci...
Show More Location
Maastricht University Medical Centre
Learn More & Join Trial
Effect of Guanfacine Extended-Release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia PHASE4 This study seeks to determine, using special sleep tests (polysomnography a...
Show More Location
Children's Specialized Hospital
Learn More & Join Trial
A Drug Interaction Study of SPD503 and Vyvanse Administered Alone and In Combination in Normal Healthy Volunteers PHASE1 Drug-drug interaction study; to examine the pharmacokinetics of SPD503 and ...
Show More Location
Advanced Biomedical Research, Inc.
Learn More & Join Trial
A Drug Interaction Study of SPD503 and Concerta Administered Alone and In Combination in Normal Healthy Volunteers PHASE1 This is a drug-drug interaction study; the purpose of this study is to exam...
Show More Location
Advanced Biomedical Research, Inc.
Learn More & Join Trial
Access to Extended Release Guanfacine HCl for Subjects Who Participated in Studies SPD503-315 or SPD503-316 in Europe PHASE3 For subjects in Europe that have already participated in either Study SPD50...
Show More Location
Medizinische Universitat Graz Univ fur Kinder
Learn More & Join Trial
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP) PHASE2 This study will evaluate the safety and tolerability of SPD503 in subjects ...
Show More Location
Birmingham Research Group, Inc
Learn More & Join Trial
Efficacy and Safety of SPD503 in Combination With Psychostimulants PHASE3 The purpose of this study is to assess the efficacy and safety of SPD503 in...
Show More Location
Harmonex Neuroscience Research
Learn More & Join Trial